Kurs
-0,91%
Kurs
-0,91%
Open
68,90
High
68,90
Low
65,10
Close
65,10
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Likviditet
0,63 MNOK
Likviditet
0,63 MNOK
Rel. mcap
0,01%
Antal aktier
9 517
Likviditet under dagen för detta pressmeddelande
Kalender
| Est. tid* | ||
| 2025-10-31 | 08:00 | Kvartalsrapport 2025-Q3 |
| 2025-07-11 | 08:00 | Kvartalsrapport 2025-Q2 |
| 2025-04-30 | 08:00 | Kvartalsrapport 2025-Q1 |
| 2025-04-28 | N/A | X-dag ordinarie utdelning AKBM 0.00 NOK |
| 2025-04-25 | - | Årsstämma |
| 2025-02-12 | - | Bokslutskommuniké 2024 |
| 2024-11-01 | - | Kvartalsrapport 2024-Q3 |
| 2024-09-09 | - | X-dag ordinarie utdelning AKBM 45.00 NOK |
| 2024-09-03 | - | Extra Bolagsstämma 2024 |
| 2024-07-12 | - | Kvartalsrapport 2024-Q2 |
| 2024-04-26 | - | Kvartalsrapport 2024-Q1 |
| 2024-04-17 | - | X-dag ordinarie utdelning AKBM 0.00 NOK |
| 2024-04-16 | - | Årsstämma |
| 2024-02-14 | - | Bokslutskommuniké 2023 |
| 2023-11-01 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-14 | - | Kvartalsrapport 2023-Q2 |
| 2023-04-28 | - | Kvartalsrapport 2023-Q1 |
| 2023-04-21 | - | X-dag ordinarie utdelning AKBM 0.00 NOK |
| 2023-04-20 | - | Årsstämma |
| 2023-02-15 | - | Bokslutskommuniké 2022 |
| 2022-11-01 | - | Kvartalsrapport 2022-Q3 |
| 2022-07-14 | - | Kvartalsrapport 2022-Q2 |
| 2022-04-29 | - | Kvartalsrapport 2022-Q1 |
| 2022-04-21 | - | X-dag ordinarie utdelning AKBM 0.00 NOK |
| 2022-04-20 | - | Årsstämma |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-10-29 | - | Kvartalsrapport 2021-Q3 |
| 2021-07-14 | - | Kvartalsrapport 2021-Q2 |
| 2021-04-29 | - | Kvartalsrapport 2021-Q1 |
| 2021-03-15 | - | X-dag ordinarie utdelning AKBM 0.00 NOK |
| 2021-03-12 | - | Årsstämma |
| 2021-02-16 | - | Bokslutskommuniké 2020 |
| 2020-10-30 | - | Kvartalsrapport 2020-Q3 |
| 2020-07-15 | - | Kvartalsrapport 2020-Q2 |
Beskrivning
| Land | Norge |
|---|---|
| Lista | Oslo Bors |
| Sektor | Handel & varor |
| Industri | Dagligvaror |
2024-04-16 16:23:35
16 April 2024: The Annual General Meeting of Aker BioMarine ASA was held today
as a digital meeting with online participation.
All proposals on the agenda were adopted, cf. Notice of Annual General Meeting
attached to the stock exchange release dated 20 March 2024.
The complete minutes are attached to this release.
For further information, please contact
Christopher Robin Vinter, VP IR & Corporate Finance
Mobile: +47 911 60 820
Email: Christopher.vinter@akerbiomarine.com
About Aker BioMarine
Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting
company developing krill-derived products for consumer health and wellness as
well as animal nutrition. The company has a strong position in its industry and
is the world's leading supplier of krill, the natural, powerful and health
promoting source of nutrients from the pristine waters of Antarctica. Aker
BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available
at www.akerbiomarine.com.